Amneal Pharmaceuticals Inc (NASDAQ: AMRX) is 0.25% higher on its value in year-to-date trading and has touched a low of $6.29 and a high of $9.48 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AMRX stock was last observed hovering at around $7.90 in the last trading session, with the day’s gains setting it 0.04%.
Currently trading at $7.94, the stock is 5.54% and 6.62% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.15 million and changing 0.51% at the moment leaves the stock -2.44% off its SMA200. AMRX registered 15.24% gain for a year compared to 6-month loss of 1.40%.
The stock witnessed a 5.87% gain in the last 1 month and extending the period to 3 months gives it a -9.05%, and is 2.06% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.41% over the week and 2.37% over the month.
Amneal Pharmaceuticals Inc (AMRX) has around 8300 employees, a market worth around $2.49B and $2.83B in sales. Fwd P/E is 9.60. Profit margin for the company is -0.46%. Distance from 52-week low is 26.23% and -16.20% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.62%).
with sales reaching $753.34M over the same period.The EPS is expected to grow by 21.55% this year, but quarterly earnings will post 7.81% year-over-year. Quarterly sales are estimated to grow 7.35% in year-over-year returns.
The shares outstanding are 313.38M, and float is at 143.62M with Short Float at 2.93%.
The top institutional shareholder in the company is UBS GROUP AG with over 21.85 million shares valued at $138.74 million. The investor’s holdings represent 7.0684 of the AMRX Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 13.99 million shares valued at $88.86 million to account for 4.5271 of the shares outstanding. The other top investors are TPG GP A, LLC which holds 12.33 million shares representing 3.9884 and valued at over $78.29 million, while BLACKROCK INC. holds 3.6499 of the shares totaling 11.28 million with a market value of $71.64 million.
Amneal Pharmaceuticals Inc (AMRX) Insider Activity
The most recent transaction is an insider sale by Patel Gautam, the company’s Director. SEC filings show that Patel Gautam sold 94,906 shares of the company’s common stock on Jun 16 ’25 at a price of $8.02 per share for a total of $0.76 million. Following the sale, the insider now owns 1.61 million shares.
Amneal Pharmaceuticals Inc disclosed in a document filed with the SEC on Jun 10 ’25 that Patel Gautam (Director) sold a total of 56,426 shares of the company’s common stock. The trade occurred on Jun 10 ’25 and was made at $8.02 per share for $0.45 million. Following the transaction, the insider now directly holds 1.7 million shares of the AMRX stock.
Still, SEC filings show that on May 16 ’25, Shah Nikita (Executive Vice President) disposed off 49,140 shares at an average price of $7.58 for $0.37 million. The insider now directly holds 388,929 shares of Amneal Pharmaceuticals Inc (AMRX).
